The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 10, 2023

Filed:

Nov. 19, 2019
Applicant:

Janssen Biotech, Inc., Horsham, PA (US);

Inventors:

Julianty Angsana, San Diego, CA (US);

Patrick Branigan, Lansdowne, PA (US);

Samuel DePrimo, Carlsbad, CA (US);

Susan Flavin, Spring City, PA (US);

Shu Li, Dresher, PA (US);

Xuejun Liu, San Diego, CA (US);

Ernesto Munoz, Santa Fe, CA (US);

Bruce Randazzo, Rydal, PA (US);

Assignee:

JANSSEN BIOTECH, INC., Horsham, PA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/24 (2006.01); A61K 39/395 (2006.01); A61P 17/06 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07K 16/244 (2013.01); A61K 39/395 (2013.01); A61P 17/06 (2018.01); C07K 16/241 (2013.01); A61K 45/06 (2013.01); C07K 2317/21 (2013.01); C07K 2317/565 (2013.01);
Abstract

A method of treating psoriasis in a patient by administering an IL-23 specific antibody, e.g., guselkumab, in a clinically proven safe and clinically proven effective amount and the patient achieves PASI90, PASI100 or IGA 0 or 1 score as measured 16, 24, 32, 40 and 48 weeks after initial treatment and the patient achieves higher efficacy than a patient treated with the secukinumab antibody.


Find Patent Forward Citations

Loading…